CLINICAL_TRIALS
trial_result
· 2018-12-14
Clinical Trial Update: A Long-Term Safety Study of ALKS 5461 [Phase 3]
Summary
Phase 3 long-term safety study of ALKS 5461 for major depressive disorder has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alkermes, Inc. | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2018-12-14